Xanthelasma palpebrarum after hyaluronic acid injection in the lower eyelid: A case report and review of the literature.

BACKGROUND: Hyaluronic acid filler treatments are a very popular nonsurgical procedure worldwide, most wanted to create a more attractive profile and correct facial aging. Since its usage has expanded, more complications have been seen. AIMS: To report a probably new adverse effect related to injectable fillers. PATIENT: A 38-year-old white woman who underwent hyaluronic acid filling in the periorbital area and presented twelve months after with two symmetrically yellowish plaque lesions on the lower eyelids, with no edema or nodules. RESULTS: The lesion appeared to be xanthelasma, in a patient with no history of hyperlipidemia. Histological analysis showed unspecific findings with rare histiocytes present in the papillary dermis. The patient was treated with hyaluronidase infiltration in both lower eyelid areas as an attempt to minimize the appearance of the lesions, with a satisfactory response. CONCLUSIONS: As hyaluronic acid fillings are becoming more popular, all physicians have to be aware of its complications. The xanthelasma-like reaction is probably a new adverse effect related to injectable fillers and it is important to be alert to this possibility.

Solitary fibrous tumor of the pleura mimicking pleural effusion

Solitary fibrous tumor of the pleura is a rare mesenchymal neoplasm of fibroblastic origin and represents less than 5% of primary tumors of the pleura. There are few reports in the literature about this disease, therefore the data on its presentation and management are derived from reports and retrospective analysis of case series from referral centers. In this report, we describe a case of a patient who presented this diagnosis during hospitalization, and following we briefly review the published literature of this pathology...

Qualificação da saúde da mulher na prevenção do câncer cervicouterino

O câncer de colo uterino é a terceira neoplasia mais incidente na população feminina no Brasil e, apesar de contar com um método preventivo eficaz, o exame de citopatológico do colo uterino, ainda é uma doença com índices altos de diagnóstico tardio e de mortalidade no Brasil. Medidas que promovam entendimento da doença, da sua possível prevenção e das complicações frente a um diagnóstico mais tardio devem ser pensadas e aplicadas com o intuito final de aumentar a aderência da coleta ao exame de citopatológico do colo uterino, atuando na prevenção e promoção de saúde da mulher.